CO76 Switching Therapy from Alglucosidase Alfa to Avalglucosidase Alfa in Patients with Late Onset Pompe Disease (LOPD): Longitudinal Assessment of Respiratory Function from the Co... by Berger, K.I., Msihid, J., Periquet, M., Riou-Franca, L., Thibault, N., An Haack, K., Pollissard, L.

Get full text

Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system by Le Lay, K., Myon, E., Hill, S., Riou-Franca, L., Scott, D., Sidhu, M., Dunlop, D., Launois, R.

Get full text

SA26 Win Ratio Analyses of Multiple Endpoints in Rare Disease Trials: A Case-Study Based on a Trial of Avaglucosidase Alfa in Late-Onset Pompe Disease (LOPD) by Ishak, KJ, Caro, JJ, Hamed, A, Riou-Franca, L, Thibault, N, Shukla, P, Berger, KI, Diaz-Manera, J, Dimachkie, MM, Boentert, M

Get full text

P4783Treatment persistence of patients with atrial fibrillation on VKA or NOAC: Data from GLORIA-AF Phase III 1-year interim analysis by Lip, G Y H, Diener, H.-C, Dubner, S J, Halperin, J L, Rothman, K J, Ma, C.-S, Lu, S, Paquette, M, Riou Franca, L, Zint, K, Teutsch, C, Huisman, M V

Get full text

P2896Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease: data from GLORIA-AF by Halperin, J L, Teutsch, C, Huisman, M V, Diener, H.-C, Rothman, K J, Ma, C S, Dubner, S J, Zint, K, Riou Franca, L, Paquette, M, Lip, G Y H

Get full text

P2887Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry by Dubner, S J, Huisman, M V, Diener, H C, Halperin, J L, Rothman, K J, Ma, C S, Bergler-Klein, J, Zint, K, Riou Franca, L, Lu, S, Teutsch, C, Paquette, M, Lip, G Y H

Get full text

P4799When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry by Paquette, M, Huisman, M V, Lip, G Y H, Diener, H.-C, Dubner, S J, Halperin, J L, Rothman, K J, Ma, C S, Lu, S, Riou Franca, L, Teutsch, C, Zint, K, Nieuwlaat, R

Get full text

Prise en charge du myélome multiple en France en 2011 : résultats de l’étude Mymosa by Grosbois, B., Facon, T., Hulin, C., Anglaret, B., Milpied, N., Tournamille, J.-F., Riou Franca, L., Bréart, G.

Get full text

200Safety of uninterrupted dabigatran in cardiovascular interventions in the GLORIA-AF registry program by Lip, GYH, Van Der Wall, S J, Teutsch, C, Rothman, K J, Diener, H-C, Dubner, S J, Ma, C S, Paquette, M, Lu, S, Riou Franca, L, Zint, K, Halperin, J L, Huisman, M V

Get full text

Early Response to Certolizumab Pegol in Rheumatoid Arthritis Predicts Outcome at One Year by Berenbaum, F, Pham, T, Fautrel, B, Joubert, J.M, De Chalus, T, Riou França, L, Claudepierre, P

Get full text

P281Baseline characteristics of patients with atrial fibrillation with and without comorbid heart failure: the GLORIA-AF registry by Dubner, SJ, Huisman, MV, Diener, H-C, Halperin, J., Rothman, KJ, Ma, C-S, Zint, K., Riou Franca, L., Lu, S., Teutsch, C., Paquette, M., Lip, GYH

Get full text

PCV16 MANAGEMENT OF GASTROINTESTINAL AND UROGENITAL BLEEDING EVENTS IN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION TREATED WITH DABIGATRAN ETEXILATE EARLY AFTER APPROVAL by Riou França, L., Petrini, M., Zint, K.

Get full text

CO122 Late-Onset Pompe Disease (LOPD) Patients Treated with Avalglucosidase Alfa Show Favorable Results Compared to Cipaglucosidase Alfa Plus Miglustat: Indirect Treatment Comparis... by Roberts, M., Proskorovsky, I., Guyot, P., Shukla, P., Periquet, M., Thibault, N., Hamed, A., Riou França, L., Pollissard, L.

Get full text

Student adjustment to higher education: the role of alternative educational pathways in coping with the demands of student life by Shankland, Rebecca, u.a

Get full text

CS4 ANTIPSYCHOTIC PATTERNS AND TREATMENT COST IN FRANCE by Riou-Franca, L, Westerloppe, J, Launois, R

Get full text

PCN7 ORAL VINORELBINE IN THE TREATMENT OF NON SMALL CELL LUNG CANCER by Le Lay, K, Riou Franca, L, Launois, R

Get full text

PMS9 - Early Response to Certolizumab Pegol in Rheumatoid Arthritis Predicts Outcome at One Year by Berenbaum, F., Pham, T., Fautrel, B., Joubert, J.M., De Chalus, T., Riou França, L., Claudepierre, P.

Get full text

Combien coûte la prise en charge d’un purpura thrombopénique immunologique chronique de l’adulte ? À propos d’une étude monocentrique de 57 cas by Khellaf, M., Eckert, L., Poitrinal, P., Francesconi, C., Haddad, A., Riou-França, L., Deuson, R., Launois, R., Godeau, B.

Get full text

PUK15 STRESS URINARY INCONTINENCE: ASSESSMENT OF WOMEN'S PREFERENCES by Riou França, L, Zylberman, M, Launois, R

Get full text

Preliminary study on the role of alternative educational pathways in promoting the use of problem-focused coping strategies by Shankland, Rebecca, França, Lionel Riou, Genolini, Christophe M., Guelfi, Julien-Daniel, Ionescu, Serban

Get full text